Important notice
We would like to inform you that Chinese Journal of Cancer has changed the title to
Cancer Communications on 1st March 2018.
Cancer Communications is
published by Wiley from 1 January 2020. The journal website is available at:
https://onlinelibrary.wiley.com/journal/25233548
Cancer Communications 2020年影响因子突破10分
Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor-associated myocarditis
Yan Xu, Yanjun Song, Xiaoyan Liu, Yuequan Shi, Yingxian Liu, Hao Qian, Xiaoxing Gao, Minjiang Chen, Ruili Pan, Jing Zhao, Wei Zhong, Wei Wu, Mengzhao Wang
PKCβII–ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity
Guang Lei, Amber Horbath, Zhuang Li, Boyi Gan
Survival trends of patients with non-metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates
Lei Huang, Lina Jansen, Rob H.A. Verhoeven, Jelle P. Ruurda, Liesbet Van Eycken, Harlinde De Schutter, Jan Johansson, Mats Lindblad, Tom B. Johannesen, Vesna Zadnik, Tina ?agar, Sjoerd M. Lagarde, Cornelis J.H. van de Velde, Petra Schrotz-King, Hermann Brenner
Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line
Chaoji Shi, Ziyue Gu, Shengming Xu, Houyu Ju, Yunteng Wu, Yong Han, Jiayi Li, Chuwen Li, Jing Wu, Lizhen Wang, Jiang Li, Guoyu Zhou, Weimin Ye, Guoxin Ren, Zhiyuan Zhang, Rong Zhou
Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials
Yang Xu, Ping Li, Yang Liu, Dijia Xin, Wen Lei, Aibin Liang, Weidong Han, Wenbin Qian
The theory of tumor ecosystem
Xueman Chen, Erwei Song
Transcriptome-wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma
Yong-Qiao He, Wen-Qiong Xue, Dan-Hua Li, Tong-Min Wang, Zhi-Ming Mai, Da-Wei Yang, Chang-Mi Deng, Ying Liao, Wen-Li Zhang, Ruo-Wen Xiao, Luting Luo, Hua Diao, Xiating Tong, Yanxia Wu, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Minzhong Tang, Yuming Zheng, Yonglin Cai, Ellen T. Chang, Zhe Zhang, Guangwu Huang, Su-Mei Cao, Qing Liu, Lin Feng, Ying Sun, Maria Li Lung, Hans-Olov Adami, Weimin Ye, Tai-Hing Lam, Wei-Hua Jia
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID-19 pandemic in Germany: A retrospective register-based cohort study
Johannes Diers, Laura Acar, Johanna C. Wagner, Philip Baum, Mohammed Hankir, Sven Flemming, Carolin Kastner, Christoph-Thomas Germer, Helmut L'hoest2, Ursula Marschall, Johan Friso Lock, Armin Wiegering
Crosstalk between IL-15Rα+ tumor-associated macrophages and breast cancer cells reduces CD8+ T cell recruitment
Wenlong Zhang, Qing Zhang, Nanfei Yang, Qian Shi, Huifang Su, Tingsheng Lin, Zhonglei He, Wenxin Wang, Hongqian Guo, Pingping Shen
Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients
Jian Shen, Na Sun, Philipp Zens, Thomas Kunzke, Achim Buck, Verena M. Prade, Jun Wang, Qian Wang, Ronggui Hu, Annette Feuchtinger, Sabina Berezowska, Axel Walch
Gastric cancer |
|
Edited by Yun Dai and Li Yan |
This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.
|
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tumor angiogenesis |
|
Edited by Francesco Pezzella
|
Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.
|
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Lung cancer |
|
 Edited by Lin Yan and Wei Zhang
|
Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.
|
CC adopts ScholarOne Manuscripts
to manage its submissions from Nov.1, 2019
Submission Guidelines
Reference style for
CC is now published by Wiley
© Cancer Communications
651 Dongfeng Road East,Guangzhou 510060, P.R.China
